What is "molly"?

“Ecstasy” and "Molly" are slang terms
for MDMA, short for 3,4-methylenedioxymethamphetamine, a name that’s nearly as
long as the all-night parties where MDMA is often used. That's why MDMA has been
called a “club drug.” It has effects similar to those of other stimulants, and
it often makes the person feel like everyone is his or her friend, even when
that’s not the case.

MDMA is
man-made—it doesn't come from a plant like marijuana or tobacco do. Other
chemicals or substances—such as caffeine, dextromethorphan (found in some cough
syrups), amphetamines, PCP, or cocaine—are sometimes added to, or substituted
for, MDMA in Ecstasy or Molly tablets. Makers of MDMA can add anything they want
to the drug, so its purity is always in question.

SLANG TERMS - There
are a lot of slang words for MDMA. “Ecstasy” and "Molly" are two of the most
common. You might also hear “E,” “XTC,” “X,” “Adam,” “hug,” “beans,” “clarity,”
“lover's speed,” and “love drug."

MOLLY FACTS

MDMA
(3,4-methylenedioxymethamphetamine), commonly referred to as ecstasy or molly,
is a drug that is sold either as a pressed pill taken orally, or as a powder
that is snorted or swallowed. MDMA’s effects resemble those of both stimulants
and psychedelics. A typical dose of 100 to 125 mg lasts four to six hours.

People who use
MDMA describe themselves as feeling open, accepting, unafraid and connected
to people around them. Typically used in
social settings, especially among the rave and dance club cultures, MDMA’s
effects are stimulated by visuals, sounds, smells and touch. Some people
experience nausea at the outset, but after about forty-five minutes, most
people report feelings of relaxation and clarity. MDMA causes dilation of
the pupils and, often, sensitivity to light. People using MDMA experience
heightened sensations and want to intensify these feelings by dancing,
talking and touching.

Most of MDMA’s
potential harms derive from the setting of its use.
Although few adverse effects have been reported, hyperthermia – a
dangerously high increase in body temperature – is the most common problem
related to ecstasy. Hyperthermic reactions result from physical exertion
(such as dancing) in an overheated environment without replenishing fluids,
which is why users take breaks and consume fluids like water or Gatorade.
Overdoses are extremely rare.

Because MDMA is
illegal – and, therefore, unregulated – it is impossible know what a “dose”
contains. In fact, many drugs sold as
“ecstasy” or “molly” are not MDMA. Besides MDMA, ecstasy pills may contain
varying levels of MDA (methylene-dioxyamphetamine), other stimulants such as
caffeine, or anesthetics such as Ketamine or dextromethorphan (DXM) – which
can significantly amplify potential harms. Testing kits are available to
detect if pills contain MDMA or another drug, but cannot determine potency
or purity.

Research
evaluating MDMA’s therapeutic and medical applications has shown promising
results. MDMA-assisted psychotherapy
combines traditional psychotherapy with the administration of MDMA. Because
of MDMA’s unique effect of diminishing fear and enhancing interpersonal
trust, it is an ideal adjunct medicine to psychotherapy, and it has been
administered to over 500 human subjects in clinical trials without a single
serious adverse event. A seminal study published in 2010 found that PTSD
patients who received MDMA-assisted psychotherapy reported overwhelming
reductions in the severity of their symptoms – reductions which were
sustained, on average, for more than three years. Such findings have been
replicated by other studies, and additional research is underway in the
U.S., Canada, Israel, U.K. and Australia.

MDMA was
initially popularized by psychotherapists and other mental health
practitioners in the late 1970s and early 1980s.
After MDMA was placed in Schedule I in 1985, a lawsuit challenging this
designation won a favorable ruling from the DEA Administrative Law Judge,
who concluded that MDMA had "currently accepted medical use" and "acceptable
safety" – yet it remains in Schedule I today. In 2002, the RAVE Act
(“Reducing Americans’ Vulnerability to Ecstasy”) inc

1 Panel Methylenedioxymethamphetamine - MDMA - Ecstasy Drug Test Dip

Description

The MDMA One Step Methylenedioxymethamphetamine Test Strip is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Methylenedioxymethamphetamine in urine.

The One Step Drug Screen Test Card yields a positive result when the Methylenedioxymethamphetamine in urine exceeds 500 ng/mL.

#DIP-MDMA - Ecstasy Drug Test Dip (dip strip)

INTENDED USE OF DRUG TEST KIT

This Molly Drug Test Panel
is an forensic, all inclusive, point of use screening test for the rapid
detection of Methamphetamines (including Ecstasy*),
Amphetamines, in human urine at or above the system concentrations levels
established as standard minimums by the National Institute on Drug Abuse (NIDA),
the World Health Organization (WHO)
and SAMHSA as shown in the chart below. Note system cut-off
concentrations are expressed in nanograms per
milliliter solution.

SUMMARY AND EXPLANATION OF DRUG TESTING

Urine based screening tests for drugs of
abuse range from simple immunoassay tests to complex analytical procedures. The
speed and sensitivity of lateral flow based immunoassays identical to that
employed in our Multi-Drug 5 Panel Drug Test have made them the most widely
accepted method for screening urine for drugs of abuse. our Multi-Drug Screen
Panel Test is based on the principle of the highly specific immunochemical
reactions of antigens and antibodies which are used for the analysis of specific
compounds in human urine. This Multi-Drug Screen Test is a rapid, visual,
competitive panel immunoassay that can be used for the simultaneous, qualitative
detection of the five (5) targeted drugs and their metabolites listed above. For
a description of these drugs of abuse along with other useful background
information please refer to the
Drug Test FAQ page. This Five Panel
Multi-Drug Test
is intended as an initial forensic screen for the presence of drug or drug
metabolites at the time the test is performed. Because the test requires visual
interpretation, it is recommended that a person other than the test subject
interpret test results.

DRUG TEST PROCEDURE

1. Read the enclosed instruction
manual completely.2. Do not open the sealed test pouch until just prior
to sample testing.3. Collect a fresh urine sample in a clean container
preferably glass.4. Check the expiration date and remove the test
device from the sealed pouch. Do not use the test past its expiration date.
Remove the test cap exposing the 10 absorbent wicks. Do not touch the wicks or
otherwise contaminate them.
5. Dip the wicks only into
the urine sample for approximately 20-30 seconds or until visible sample
migration up the wicks and across
the tests panels is observed. 6. Dip only the wicks. Do not allow
the sample to come in contact with any other part of the test device or its
plastic housing.7. Read result within 3 to 8 minutes after the
addition of samples. Do not read result after 8 minutes. If the drug test is
left standing for longer than 8 minutes, the intensity of the colored lines may
change or for technical reasons, a faint line may appear that should not be
interpreted.8. Photocopy both sides of the test
card for a permanent record of test results.

INTERPRETATION OF DRUG TEST RESULTS

Negative: Colored lines adjacent to each target drug name and in
the control (C) regions will appear. The color intensity of the line for the
target drug may be weaker or stronger than that of the control line however any
line, no matter how faint should be interpreted as a negative result. Do not
attempt to correlate the intensity or color of the test lines between the
targeted drug panels. Also because development times vary for each target drug,
results should not fully interpreted until 6-8 minutes
have elapsed. Some drug panels, however, will develop test lines within 3
minutes or less producing negative results.A very faint line on the test region may indicate that the target drug in
the sample is near the cutoff level for the test. While these results should be
considered negative, confirmation of the sample by more analytical testing
methods may be desired.

Positive:
Colored lines appear in the control regions (C) but do not develop in the test
region. The absence of any line in any target drug test region indicates a
positive result for that drug or drug metabolite. The example shown is a
positive test for THC
and Opiates
and negative test for all other drugs. Note that test lines are not of equal
intensity or color. Because of the various sensitivity cutoff level for each
specific drug this result is normal.Invalid: No line appears
in the control region. Under no circumstances should a positive sample be
identified until the control line (C) forms in the control test area. If the
control line (C) does not form, the test result is inconclusive and the assay
should be repeated with a new test device.

Note: our Molly Drug test panel is used to obtain visual qualitative result
and is not intended as a quantitative assay.. This assay provides only a
preliminary analytical test result as to the presence of the target drug and
drug metabolites at the established minimum standards above. A more specific
alternative chemical method must be used in order to obtain a confirmed
analytical result. Gas chromatography! mass spectrometry (GC/MS) has been
established as the preferred confirmatory method by the Substance Abuse Mental
Health Services Administration (SAMHSA). Clinical consideration and professional
judgment should be applied to any drug of abuse test result, particularly when
preliminary positive results are indicated. If confirmation of positive drug
test is required, we suggest
Laboratory Confirmation of positive drug test results.